Hirtle Callaghan & Co’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,674
| Closed | -$259K | – | 83 |
|
|
2023
Q1 | $259K | Sell |
1,674
-11,333
| -87% | -$1.83M | 0.01% | 79 |
|
|
2022
Q4 | $2.3M | Buy |
13,007
+6,270
| +93% | +$1.08M | 0.14% | 50 |
|
|
2022
Q3 | $1.1M | Sell |
6,737
-1,539
| -19% | -$260K | 0.08% | 67 |
|
|
2022
Q2 | $1.47M | Sell |
8,276
-521
| -6% | -$92.8K | 0.09% | 55 |
|
|
2022
Q1 | $1.56M | Buy |
8,797
+5,361
| +156% | +$912K | 0.08% | 51 |
|
|
2021
Q4 | $588K | Buy |
+3,436
| New | +$563K | 0.03% | 62 |
|
|
2019
Q1 | – | Sell |
-14,600
| Closed | -$1.88M | – | 102 |
|
|
2018
Q4 | $1.88M | Hold |
14,600
| – | – | 0.16% | 27 |
|
|
2018
Q3 | $2.02M | Hold |
14,600
| – | – | 0.18% | 26 |
|
|
2018
Q2 | $1.77M | Hold |
14,600
| – | – | 0.16% | 26 |
|
|
2018
Q1 | $1.87M | Hold |
14,600
| – | – | 0.17% | 26 |
|
|
2017
Q4 | $2.04M | Sell |
14,600
-402
| -3% | -$56K | 0.19% | 24 |
|
|
2017
Q3 | $1.95M | Buy |
15,002
+14,600
| +3,632% | +$1.94M | 0.19% | 24 |
|
|
2017
Q2 | $54K | Sell |
402
-100
| -20% | -$12.8K | 0.01% | 61 |
|
|
2017
Q1 | $62K | Hold |
502
| – | – | 0.01% | 57 |
|
|
2016
Q4 | $58K | Sell |
502
-14,895
| -97% | -$1.72M | 0.01% | 58 |
|
|
2016
Q3 | $1.82M | Hold |
15,397
| – | – | 0.38% | 21 |
|
|
2016
Q2 | $1.87M | Sell |
15,397
-334
| -2% | -$38K | 0.35% | 20 |
|
|
2016
Q1 | $1.7M | Buy |
15,731
+12,113
| +335% | +$1.25M | 0.32% | 19 |
|
|
2015
Q4 | $371K | Sell |
3,618
-2,341
| -39% | -$235K | 0.09% | 20 |
|
|
2015
Q3 | $556K | Hold |
5,959
| – | – | 0.09% | 16 |
|
|
2015
Q2 | $581K | Buy |
+5,959
| New | +$597K | 0.2% | 15 |
|
|
2015
Q1 | – | Sell |
-50,493
| Closed | -$5.28M | – | 195 |
|
|
2014
Q4 | $5.28M | Sell |
50,493
-4,100
| -8% | -$432K | 1.22% | 14 |
|
|
2014
Q3 | $5.82M | Sell |
54,593
-400
| -0.7% | -$41.5K | 0.96% | 18 |
|
|
2014
Q2 | $5.75M | Hold |
54,993
| – | – | 0.8% | 25 |
|
|
2014
Q1 | $5.4M | Sell |
54,993
-528
| -1% | -$49K | 0.89% | 21 |
|
|
2013
Q4 | $5.08M | Hold |
55,521
| – | – | 0.68% | 21 |
|
|
2013
Q3 | $4.81M | Buy |
55,521
+51,238
| +1,196% | +$4.6M | 0.78% | 21 |
|
|
2013
Q2 | $368K | Buy |
+4,283
| New | +$363K | 4.26% | 7 |
|
Other funds holding JNJ
Hirtle Callaghan & Co's JNJ Position: Q2 2023 in Review
Hirtle Callaghan & Co sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 1,674 shares — an estimated $259K sold.
Hirtle Callaghan & Co first reported a position in JNJ in Q2 2013 and held it in 28 quarters. The position peaked at $5.82M in Q3 2014. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.
- Hirtle Callaghan & Co reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
- Hirtle Callaghan & Co sold 1,674 Johnson & Johnson shares in Q2 2023, an estimated $259K.
- Hirtle Callaghan & Co first reported a position in Johnson & Johnson in Q2 2013 and held it in 28 quarters.
- Hirtle Callaghan & Co's Johnson & Johnson position peaked at $5.82M in Q3 2014.
- 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.
Based on Hirtle Callaghan & Co's 13F filing for Q2 2023, filed 10 Aug 2023.